ArticleJACC. Case reports2025
Very Late Coronary Thrombosis After Drug-Coated Balloon Treatment: An Old Problem With a New Therapy.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEvidence underlying the use of drug-coated balloons (DCBs) as an alternative to drug-eluting stents in coronary de novo lesions is poor. CASE SUMMARY: We present a case of a 72-year-old man with an ST-elevation myocardial infarction due to very late thrombosis of a lesion previously treated with DCB in the context of an ST-elevation myocardial infarction. DISCUSSION: Long-term outcomes of DCBs in coronary percutaneous intervention have not been fully explored. Despite the concept of leaving nothing behind, we herein show a very late lesion thrombosis after DCB treatment. TAKE-HOME MESSAGE: Very late thrombosis after the use of DCBs in de novo coronary lesions should be considered as a potential complication with subsequent clinical consequences, especially when large coronary vessels are involved.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.